Eli Lilly and Company (LLY) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped LLY stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Eli Lilly stands as the preeminent mega-cap pharmaceutical growth engine, propelled by historic demand for its dual GIP/GLP-1 receptor agonist portfolio (Mounjaro and Zepbound) and superior commercial execution reflected in 8 consecutive quarters of earnings beats. With projected top-line growth exceeding 27% and a fortified pipeline featuring oral candidate orforglipron and triple agonist retatrutide, Lilly is poised to expand its market leadership in the multi-hundred-billion-dollar cardiometabolic sector. While high valuation multiples and geopolitical/regulatory drug pricing pressures represent genuine tail risks, the company's aggressive manufacturing build-out and multi-indication label expansions provide an exceptionally strong foundation for durable multi-year alpha generation. The saved 1-year distribution is P10 $1,120, P50 $1,520, and P90 $1,800.
Last analyzed · Model: gemini-3.8-flash
Eli Lilly and Company Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $1,120 | Pessimistic plausible scenario |
| P50 | $1,520 | Median scenario |
| P90 | $1,800 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Robust top-line growth of ~28%, driven by unyielding demand for tirzepatide (Mounjaro and Zepbound), an 8-quarter earnings beat streak, and expanding manufacturing capacity that continues to alleviate historical supply constraints.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this LLY analysis generated?
October 29, 2026.
Is this a guaranteed LLY prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full LLY stock analysis · LLY sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.